Evidence map›Paper›PMID 24550726›Full record

ArticlePLoS pathogens2014

Genome-wide RNAi screen identifies broadly-acting host factors that inhibit arbovirus infection.

Ari Yasunaga, Sheri L Hanna, Jianqing Li, Hyelim Cho, Patrick P Rose, Anna Spiridigliozzi, Beth Gold, Michael S Diamond, Sara Cherry

Abstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ari YasunagaDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America ; Penn Genome Frontiers Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Sheri L HannaDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America ; Penn Genome Frontiers Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Jianqing LiDepartments of Medicine, Molecular Microbiology, Pathology & Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America.
Hyelim ChoDepartments of Medicine, Molecular Microbiology, Pathology & Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America.
Patrick P RoseDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America ; Penn Genome Frontiers Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Anna SpiridigliozziDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America ; Penn Genome Frontiers Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Beth GoldDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America ; Penn Genome Frontiers Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Michael S DiamondDepartments of Medicine, Molecular Microbiology, Pathology & Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America.
Sara CherryDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America ; Penn Genome Frontiers Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2003 to 2013
$91.5M
The role of autophagy in innate anti-viral immunity in DrosophilaR01AI074951 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2007 to 2017
$4.2M
Innate Immune Control of West Nile VirusR01AI104002 · NIAID · UNIVERSITY OF WASHINGTON · PI DIAMOND, MICHAEL S, GALE, MICHAEL · 2013 to 2017
$3.7M
ISG CONTROL OF FLAVIVIRUS INFECTIONR01AI104972 · NIAID · WASHINGTON UNIVERSITY · PI CHANDA, SUMIT K, DIAMOND, MICHAEL S · 2013 to 2017
$3.0M
Dissecting the alphavirus entry receptor NRAMPR01AI095500 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2012 to 2015
$1.9M
Defining the determinants on the alphavirus receptor NRAMP required for virus binR21AI103441 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2013 to 2014
$440k
Identification of Host Factors Impacting Rift Valley Fever Virus PathogenesisF32AI080111 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HANNA, SHERI LYNN · 2009 to 2010
$102k
NIAID NIH HHS F32 AI080111NIAID NIH HHS F32AI80111NIAID NIH HHS R01 AI074951NIAID NIH HHS R01AI074951NIAID NIH HHS R01 AI095500NIAID NIH HHS R01AI095500NIAID NIH HHS R01 AI104002NIAID NIH HHS R01 AI104972NIAID NIH HHS R01AI104972NIAID NIH HHS R21 AI103441NIAID NIH HHS R21AI103441NIAID NIH HHS U54 AI057168NIAID NIH HHS U54AI057168
6 · The paper itself

Abstract

Vector-borne viruses are an important class of emerging and re-emerging pathogens; thus, an improved understanding of the cellular factors that modulate infection in their respective vertebrate and insect hosts may aid control efforts. In particular, cell-intrinsic antiviral pathways restrict vector-borne viruses including the type I interferon response in vertebrates and the RNA interference (RNAi) pathway in insects. However, it is likely that additional cell-intrinsic mechanisms exist to limit these viruses. Since insects rely on innate immune mechanisms to inhibit virus infections, we used Drosophila as a model insect to identify cellular factors that restrict West Nile virus (WNV), a flavivirus with a broad and expanding geographical host range. Our genome-wide RNAi screen identified 50 genes that inhibited WNV infection. Further screening revealed that 17 of these genes were antiviral against additional flaviviruses, and seven of these were antiviral against other vector-borne viruses, expanding our knowledge of invertebrate cell-intrinsic immunity. Investigation of two newly identified factors that restrict diverse viruses, dXPO1 and dRUVBL1, in the Tip60 complex, demonstrated they contributed to antiviral defense at the organismal level in adult flies, in mosquito cells, and in mammalian cells. These data suggest the existence of broadly acting and functionally conserved antiviral genes and pathways that restrict virus infections in evolutionarily divergent hosts.

Indexed as

AnimalsCulicidaeDNA HelicasesDrosophila melanogasterDrosophila ProteinsExportin 1 ProteinFlavivirusFlavivirus InfectionsGenome-Wide Association StudyHost-Parasite InteractionsHumansKaryopherinsReceptors, Cytoplasmic and NuclearReverse Transcriptase Polymerase Chain ReactionRNA, Small InterferingWest Nile virusDNA HelicasesDrosophila ProteinsExportin 1 ProteinKaryopherinspont protein, DrosophilaReceptors, Cytoplasmic and NuclearRNA, Small Interfering

Identifiers

PMID24550726
PMCPMC3923753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.